Anti-Angiogenic Ophthalmic Agent Market: Targeted Therapies Transforming Retinal Disease Management
Market Overview The Anti-Angiogenic Ophthalmic Agent Market is expanding rapidly as anti-VEGF therapies continue transforming treatment outcomes for age-related macular degeneration, diabetic retinopathy, and related retinal vascular conditions. The market is projected to grow through 2030, driven by rising prevalence of age-related macular degeneration, growing diabetic retinopathy diagnosis...
0 Комментарии 0 Поделились 5 Просмотры 0 предпросмотр
BuzzingAbout https://www.buzzingabout.com